CIMAvax-EGF lung cancer vaccine
CIMAvax-EGF (vacuna terapéutica contra el cáncer de pulmón)
- Date
- 2008 · confidence high
- Place
- Centre for Molecular Immunology, Havana, Cuba
- Credited to
- Centre for Molecular Immunology (Gisela González and collaborators)
- Field
- Life & health
⚠️ Disputed: the sources disagree.
What it is
A vaccine that induces antibodies against the body's own epidermal growth factor, depriving the tumour of a proliferation signal. Registered in Cuba in 2008 for advanced lung cancer.
The survival benefit in trials is modest and limited to subgroups.
What it led to
- clinical trials in the United States and other countries
- immunotherapy against growth factors